ATM and neuroblastoma: ATM activation is a current indicator of resistance to chemotherapy agents temozolomide and irinotecan in ALT neuroblastoma cells; thus, inhibition of Ataxia telangiectasia mutated (ATM) could sensitize these tumors to treatment [153].